Ms. Hassan (for herself and Mr. Budd) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
To require the Secretary of Health and Human Services to make determinations of the exclusivity periods for which licensed biological products are eligible.
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. Senate. Medication Competition Act. S. 4332. 119th
Cong., 2nd
sess., Introduced in Senate April 16, 2026. https://www.govinfo.gov/app/details/BILLS-119s4332is.
APA
Congress, Senate (2026, April 16). Medication Competition Act (S. 4332 (IS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119s4332is.
MLA
United States, Congress, Senate. Medication Competition Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119s4332is. 119th Congress, S. 4332, Introduced in Senate 16 Apr. 2026.
